Risk evaluation and mitigation strategy (REMS) programs help ensure that the benefits of certain high-risk medications outweigh their risks. With the routine use of REMS programs, however, concerns ...
The era of historically low interest rates in the U.S. is over. Amidst aggressive moves from the Federal Reserve to curb inflation, businesses are facing a volatile rate environment for the first time ...
Mark Spitznagel, founder and chief investment officer of Universa Investments, is known for having a different way of looking at risk mitigation. And when he took the stage at the SALT New York asset ...
The Pacer Trendpilot 100 ETF aims to provide investors with long exposure to the Nasdaq 100 during rising markets while avoiding market downturns. PTNQ has significantly underperformed the Nasdaq 100 ...
Mark Spitznagel's Universa Investments returned a massive 4,144% in the first quarter of last year. The hedge fund manager told Insider in an interview that the markets are in uncharted territory. He ...
June 27 (Reuters) - (This June 27 story has been corrected to reflect that Bristol Myers owns full rights to therapy Abecma in paragraph 4. The error had also ...
Blindly holding a 50/50-stock/bond portfolio doesn’t work anymore. Volatility demands risk mitigation, and the 40-year bond rally has no more room to run. Forget what was normal before. Risk ...
In today’s financially uncertain environment, colleges and universities face numerous challenges threatening their sustainability. Rising operational costs, declining enrollment, unstable endowments, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results